Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Prioritization of Generic Drug Review.

Toufanian M, Peters JR, Uhl K.

JAMA Intern Med. 2017 Jan 1;177(1):140-141. doi: 10.1001/jamainternmed.2016.7811. No abstract available.

PMID:
28030732
2.

High-cost generic drugs--implications for patients and policymakers.

Uhl K, Peters JR, Flanagan K.

N Engl J Med. 2015 Feb 12;372(7):685-6. doi: 10.1056/NEJMc1415471#SA1. No abstract available.

PMID:
25671270
3.

Burden of changes in generic pill appearance.

Uhl K, Peters JR.

Ann Intern Med. 2014 Dec 2;161(11):839. doi: 10.7326/L14-5028. No abstract available.

PMID:
25437414
4.

Development of performance matrix for generic product equivalence of acyclovir topical creams.

Krishnaiah YS, Xu X, Rahman Z, Yang Y, Katragadda U, Lionberger R, Peters JR, Uhl K, Khan MA.

Int J Pharm. 2014 Nov 20;475(1-2):110-22. doi: 10.1016/j.ijpharm.2014.07.034. Epub 2014 Jul 30.

PMID:
25089511
5.

β-Glucosidase 2 (GBA2) activity and imino sugar pharmacology.

Ridley CM, Thur KE, Shanahan J, Thillaiappan NB, Shen A, Uhl K, Walden CM, Rahim AA, Waddington SN, Platt FM, van der Spoel AC.

J Biol Chem. 2013 Sep 6;288(36):26052-66. doi: 10.1074/jbc.M113.463562. Epub 2013 Jul 23.

6.

Twenty-first-century neuroscience: the potential for innovative therapies for brain disorders.

Miksys SL, Uhl K, Tyndale RF.

Clin Pharmacol Ther. 2012 Feb;91(2):153-7. doi: 10.1038/clpt.2011.310. No abstract available.

PMID:
22261679
7.

Temporal relationship between substance use and delinquent behavior among young psychiatrically hospitalized adolescents.

Becker SJ, Nargiso JE, Wolff JC, Uhl KM, Simon VA, Spirito A, Prinstein MJ.

J Subst Abuse Treat. 2012 Sep;43(2):251-9. doi: 10.1016/j.jsat.2011.11.005. Epub 2011 Dec 23.

8.

Adverse effects in women: implications for drug development and regulatory policies.

Parekh A, Fadiran EO, Uhl K, Throckmorton DC.

Expert Rev Clin Pharmacol. 2011 Jul;4(4):453-66. doi: 10.1586/ecp.11.29. Review.

PMID:
22114855
9.

Psychological, peer, and family influences on smoking among an adolescent psychiatric sample.

Nargiso JE, Becker SJ, Wolff JC, Uhl KM, Simon V, Spirito A, Prinstein MJ.

J Subst Abuse Treat. 2012 Apr;42(3):310-8. doi: 10.1016/j.jsat.2011.07.010. Epub 2011 Sep 22.

10.

Cognitive-behavioral therapy for adolescent depression and suicidality.

Spirito A, Esposito-Smythers C, Wolff J, Uhl K.

Child Adolesc Psychiatr Clin N Am. 2011 Apr;20(2):191-204. doi: 10.1016/j.chc.2011.01.012. Review.

11.

Sex and lifestyle drugs: the pursuit of the fountain of youth.

Kim MJ, Uhl K.

Clin Pharmacol Ther. 2011 Jan;89(1):3-9. doi: 10.1038/clpt.2010.263. No abstract available.

PMID:
21170060
12.

International consensus for a definition of disease flare in lupus.

Ruperto N, Hanrahan LM, Alarcón GS, Belmont HM, Brey RL, Brunetta P, Buyon JP, Costner MI, Cronin ME, Dooley MA, Filocamo G, Fiorentino D, Fortin PR, Franks AG Jr, Gilkeson G, Ginzler E, Gordon C, Grossman J, Hahn B, Isenberg DA, Kalunian KC, Petri M, Sammaritano L, Sánchez-Guerrero J, Sontheimer RD, Strand V, Urowitz M, von Feldt JM, Werth VP, Merrill JT; Lupus Foundation of America, Inc. International Flare Consensus Initiative.

Lupus. 2011 Apr;20(5):453-62. doi: 10.1177/0961203310388445. Epub 2010 Dec 10.

PMID:
21148601
13.

Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development.

Min SS, Turner JR, Nada A, DiMino TL, Hynie I, Kleiman R, Kowey P, Krucoff MW, Mason JW, Phipps A, Newton-Cheh C, Pordy R, Strnadova C, Targum S, Uhl K, Finkle J.

Am Heart J. 2010 May;159(5):716-29. doi: 10.1016/j.ahj.2010.02.004. Review.

PMID:
20435178
14.

Bisphenol A exposure leads to specific microRNA alterations in placental cells.

Avissar-Whiting M, Veiga KR, Uhl KM, Maccani MA, Gagne LA, Moen EL, Marsit CJ.

Reprod Toxicol. 2010 Jul;29(4):401-6. doi: 10.1016/j.reprotox.2010.04.004. Epub 2010 Apr 24.

15.

Pharmacotherapy for depressed pregnant women: overcoming obstacles to gathering essential data.

Wisner KL, Appelbaum PS, Uhl K, Goldkind SF.

Clin Pharmacol Ther. 2009 Oct;86(4):362-5. doi: 10.1038/clpt.2009.160.

PMID:
19763116
16.

Drug delivery in the twenty-first century: a new paradigm.

Smith B, Uhl K.

Clin Pharmacol Ther. 2009 May;85(5):451-5. doi: 10.1038/clpt.2009.31. No abstract available.

PMID:
19381145
17.

Assessing proarrhythmic potential of drugs when optimal studies are infeasible.

Rock EP, Finkle J, Fingert HJ, Booth BP, Garnett CE, Grant S, Justice RL, Kovacs RJ, Kowey PR, Rodriguez I, Sanhai WR, Strnadova C, Targum SL, Tsong Y, Uhl K, Stockbridge N.

Am Heart J. 2009 May;157(5):827-36, 836.e1. doi: 10.1016/j.ahj.2009.02.020. Review.

PMID:
19376308
18.

New precompetitive paradigms: focus on cardiac safety.

Finkle J, Bloomfield D, Uhl K, Sanhai W, Stockbridge N, Krucoff MW.

Am Heart J. 2009 May;157(5):825-6. doi: 10.1016/j.ahj.2009.02.021. No abstract available.

PMID:
19376307
19.

Increasing participation of women in early phase clinical trials approved by the FDA.

Pinnow E, Sharma P, Parekh A, Gevorkian N, Uhl K.

Womens Health Issues. 2009 Mar-Apr;19(2):89-93. doi: 10.1016/j.whi.2008.09.009.

PMID:
19272558
20.

Improving the quality of care for women with cardiovascular disease: report of a DCRI Think Tank, March 8 to 9, 2007.

Berger JS, Bairey-Merz CN, Redberg RF, Douglas PS; DCRI Think Tank.

Am Heart J. 2008 Nov;156(5):816-25, 825.e1. doi: 10.1016/j.ahj.2008.06.039. Epub 2008 Sep 18. Review.

PMID:
19061693

Supplemental Content

Loading ...
Support Center